Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 95Breast Neoplasms 12Neoplasms 7Leiomyoma 4Rare Diseases 2Polycystic Ovary Syndrome 2Neoplasm Metastasis 2Adenocarcinoma 2Uveal Melanoma 1Uterine Neoplasms 1Urogenital Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Skin Neoplasms 1Skin Diseases 1Sexual Dysfunction, Physiological 1Respiratory Tract Diseases 1Prostatic Diseases 1Primary Dysautonomias 1Premenopausal Breast Cancer 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Patient Compliance 1Newly Diagnosed Oligometastatic Prostate Cancer 1Neoplasms, Glandular and Epithelial 1Myofibroma 1Myelodysplastic Syndromes 1Melanoma 1Lymphatic Metastasis 1Lower Urinary Tract Symptoms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1

Interventions

Gefitinib 3Erlotinib Hydrochloride 3sotorasib 1pralsetinib 1osimertinib 1ficlatuzumab 1exemestane 1entinostat 1durvalumab 1cobimetinib 1camrelizumab 1Tyrosine Kinase Inhibitors 1Radiosurgery 1Prednisone 1Pemetrexed 1Leuprolide 1Dasatinib 1Carboplatin 1Afatinib 1AZD3759 14-((1,4,8,11-tetraazacyclotetradec-1-yl)methyl)benzoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Respiratory Tract Diseases × Leuprolide × Clear all
NCT00004436 2015-03-25

Randomized Study of Hormonal Regulation of Infantile Hemangioma

FDA Office of Orphan Products Development

Phase NA Completed
30 enrolled

Hemangioma, Respiratory Tract Diseases, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡